Sampre Nutritions Ltd Plans Strategic Fundraising Initiative to Drive Growth and Expansion
The proposed capital raise may involve issuance of eligible securities of the company, in one or more ways, through public and/or private offerings, including by way of preferential issue, qualified institutions placement and / or further public offering, subject to such approvals as may be required, including approval of the shareholders of the Company. The aim is to strengthen the company's financial structure and support its ongoing expansion and diversification efforts.
The management of the company commented 'This is an important step in our journey as we explore ways to expand operations, extend market penetration, and invest in long-term growth. The fundraising initiative highlights our commitment towards building a stronger, more resilient future at Sampre Nutritions Limited'
As part of the process, the Board will also consider convening an Extraordinary General Meeting (EGM) or initiating a postal ballot to seek shareholder approval.
Earlier in April 2024, the company successfully allotted 17 lakh equity shares at Rs 36 each following the conversion of warrants issued on a preferential basis.
On October 14, 2024, the Board approved the conversion of 85 Foreign Currency Convertible Bonds (FCCBs), originally allotted on June 28, 2024, into equity shares. This resulted in the allotment of 1,19,42,116 fully paid-up equity shares of face value of Rs 10 at a conversion price of Rs 59.84 per share, increasing the company's paid-up capital to Rs. 2.09 crore comprising of 20,91,212 equity shares of face value of Rs. 10 each.
Subsequently, in October 2024, the company received in-principle approval from BSE for listing of 89,91,711 equity shares of face value of Rs 10 each at a price of Rs 59.84 per equity share. Along with this, the company also received approval for issuance of 10,00,000 warrants convertible into equity shares of face value of Rs 10 each at a price of Rs 60.50 per equity share on a preferential basis.
In November 2024, the company approved the allotment of 8,40,000 warrants on a preferential basis to non-promoters at a price of Rs 60.50 per warrant, each convertible into one equity share of face value Rs 10.
The company was also awarded the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact.
The company recently announced its Q4 FY25 and FY25 consolidated financial result. The consolidated revenue from operations remained stable at Rs 25.12 crore. The company reported a consolidated net loss of Rs 7.67 crore, mainly on account of investment into subsidiaries and higher finance costs. For Q4 FY25, company reported revenue of Rs 7.76 crore, a growth from Rs 4.76 crores reported in Q4 FY24.
About Sampre Nutritions Ltd:
Incorporated in 1991 and headquartered in Medchal, Telangana, Sampre Nutritions Ltd is engaged in manufacturing complete range of confectionery, éclairs, candies, lollipops, toffees, powder and centre filled products. The company is instrumental to deliver the growing volumes for most of the MNC's and beside producing its own brand. The group is one stop shop for complete range of confectionary productions. It has multiple MNC's as their clients as Mondelez India Pvt Ltd, Perfetti Van Melle, Reliance, DS Group, Nestle to name a few… The promoter is also the President for Indian Confectionery Manufacturers Association and is into the industry for the past 4 decades
Sampre Nutrition is the first ISO certified company in South East Asia in this category since 1995 and is the 1st HACCP Certified Company by BVQI and FSSA Version 6 certified company with receiving Multiple Quality Awards World Wide. Further the company is associated with Mondelez India Pvt Ltd for manufacturing Eclairs for the past 30 Years and the Sole Manufacturer for Eclairs for the past 8 years for India, China and South African Market.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
32 minutes ago
- New Indian Express
Medi Assist Healthcare buys Paramount TPA for Rs 312 crore
MUMBAI: The Bengaluru-based third-party insurance service provider Medi Assist Healthcare Services has acquired 100% stake in the rival firm Paramount Health Services & Insurance TPA for a total consideration of around Rs 312 crore. This acquisition marks pivotal step in Medi Assist's continued growth strategy, reinforcing its position as the country's largest health benefits administrator. The transaction adds Rs 4,000 crore of health premia under administration to the only publicly traded company in this segment in India, Medi Assist said in a statement on Wednesday.
Hans India
34 minutes ago
- Hans India
Sensex, Nifty end lower as investors turn cautious over Trump's tariff deadline
Mumbai: The stock markets ended lower on Wednesday, as investor sentiment remained cautious due to US President Donald Trump's firm stand on the upcoming tariff deadline. The nervousness led to a risk-off mood among investors, pulling the benchmark indices lower. After rising to an intra-day high of 83,935.29, the Sensex lost momentum and closed at 83,409.69, down 287.6 points or 0.34 per cent. The Nifty also declined by 88.45 points or 0.35 per cent to end the day at 25,453.4. "Mixed global cues, particularly ahead of the impending tariff deadline, are driving investor caution,' Vinod Nair of Geojit Investments Limited said. 'Market attention is gradually shifting to crucial Q1 earnings, which have high expectations,' he added. Nair added that the underlying trends such as robust macroeconomic fundamentals and increased government expenditure continue to support market resilience. Among the Sensex stocks, the biggest losers were Bajaj Finserv, L&T, Bajaj Finance, HDFC Bank, and Bharat Electronics. On the other hand, Tata Steel, Asian Paints, Ultratech Cement, Trent, Maruti, and Sun Pharma were among the top gainers. Broader markets followed a similar trend. The Nifty Midcap100 index ended down by 0.14 per cent, while the Nifty Smallcap100 index slipped 0.41 per cent. Sector-wise, Nifty Metal, Consumer Durables, Auto, IT, Pharma, and Healthcare managed to close in the green. However, Nifty Realty, Financial Services, Bank, Oil & Gas, and Media dragged the overall sentiment with losses. The total market capitalisation of all listed companies on the NSE stood at Rs 5.35 trillion. Meanwhile, the India VIX, which measures market volatility, eased slightly by 0.66 per cent to settle at 12.44 points -- suggesting some cooling off in investor nervousness despite the day's losses. Gold traded in a narrow range as market awaits key US data releases. Comex Gold moved between $3327 – $3340, while MCX Gold traded between Rs 97,000 – Rs 97,400. 'The prices expected to remain in the broader range of Rs 96,500 – Rs 97,850 as participants price in potential dollar weakness and upcoming US data, including Non-Farm Payrolls (NFP), ADP non-farm employment, and unemployment figures,' Jateen Trivedi of LKP Securities stated.
India Gazette
34 minutes ago
- India Gazette
India's fiscal consolidation & capex boost went hand-in-hand in Apr-May FY26: UBI Report
New Delhi [India], July 2 (ANI): India has made a promising start to the financial year 2025-26 (FY26), as both fiscal consolidation and capital expenditure (capex) are moving forward together, according to a report by Union Bank of India. The report highlighted that the fiscal deficit for April-May FY26 stood at just Rs 0.13 lakh crore, which is only 0.8 per cent of the Budget Estimates (BE). This is a major improvement compared to the same period last year, when the fiscal deficit was Rs 0.51 lakh crore or 3.2 per cent of the Revised Estimates (RE). The better fiscal position has been supported by a strong rise in revenue receipts, especially a record dividend of Rs 2.69 lakh crore from the Reserve Bank of India (RBI). It stated, 'Overall, the financial year has taken off on a promising note from the perspective of the government's contribution to growth dynamics'. The report also mentioned that the revenue receipts in April-May FY26 rose by 24 per cent year-on-year. Tax revenues increased by 10 per cent, while non-tax revenues jumped by 41.8 per cent. Meanwhile, the government continued its focus on capital spending to support economic growth. Capex in April-May FY26 increased by 54 per cent year-on-year to Rs 2.21 lakh crore, compared to Rs 1.44 lakh crore in the same period last year. This represents 19.7 per cent of the total capex budgeted for the year at Rs 11.21 lakh crore, showing that the government is frontloading spending to stimulate demand. To fund the fiscal deficit, the government used a mix of market borrowings and small savings. Market borrowings were Rs 0.98 lakh crore (9 per cent of BE) and small savings contributed Rs 0.63 lakh crore (18 per cent of BE). In addition, the government's cash balance stood strong at Rs 3.27 lakh crore as of May 2025, giving it flexibility to support further expenditure. The report noted that the big RBI dividend has opened up additional policy space for capex by around Rs 60,000 crore or 0.15 per cent of GDP. While there is a chance that slower GDP growth due to lower inflation could affect fiscal targets, It added that the government remains committed to reducing the fiscal deficit to 4.4 per cent of GDP in FY26, it may be lowered it further down to around 4.2-4.3 per cent. Overall, the data for April and May shows that the government is maintaining a balance between fiscal discipline and growth-supportive spending. (ANI)
